NCT01164735
- Conditions
- Recurrent Uterine Corpus Carcinoma, Stage III Uterine Corpus Cancer, Stage IV Uterine Corpus Cancer
- Locations
-
- Gynecologic Oncology Group Philadelphia, Pennsylvania, United States
Clinical trial condition
Stage IV Uterine Corpus Cancer
Explore clinical trials studying Stage IV Uterine Corpus Cancer. Study availability and eligibility vary by location and protocol.
10 public trials
0 recruiting studies
Stage IV Uterine Corpus Cancer trial results
Completed
Racial and Genetic Biomarkers of Response in Tissue Samples From Patients With Endometrial Cancer
NCT01198171
- Conditions
- Stage I Uterine Corpus Cancer, Stage II Uterine Corpus Cancer, Stage III Uterine Corpus Cancer, +1 more
- Locations
-
- Gynecologic Oncology Group Philadelphia, Pennsylvania, United States
NCT01344837
- Conditions
- Endometrial Serous Adenocarcinoma, Stage I Uterine Corpus Cancer, Stage II Uterine Corpus Cancer, +2 more
- Locations
-
- Gynecologic Oncology Group Philadelphia, Pennsylvania, United States
NCT03112668
- Conditions
- Breast Diseases, Breast Neoplasms, Colonic Diseases, +80 more
- Locations
-
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
NCT01098630
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +28 more
- Locations
-
- Gynecologic Oncology Group of Arizona Phoenix, Arizona, United States
- University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
- Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States
- Roy and Patricia Disney Family Cancer Center Burbank, California, United States
NCT01208467
- Conditions
- Endometrial Adenocarcinoma, Recurrent Uterine Corpus Carcinoma, Stage I Uterine Corpus Cancer, +3 more
- Locations
-
- Gynecologic Oncology Group Philadelphia, Pennsylvania, United States
NCT00897442
- Conditions
- Adenoma, Adnexal Diseases, Borderline Ovarian Clear Cell Tumor, +143 more
- Locations
-
- Highlands Oncology Group PA - Fayetteville Fayetteville, Arkansas, United States
- Washington Regional Medical Center - Fayetteville Fayetteville, Arkansas, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States
Completed
Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus
NCT00064025
- Conditions
- Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation, +5 more
- Locations
-
- Gynecologic Oncology Group Philadelphia, Pennsylvania, United States
NCT00005830
- Conditions
- Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, +2 more
- Locations
-
- Gynecologic Oncology Group Philadelphia, Pennsylvania, United States
NCT00005840
- Conditions
- Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Stage III Uterine Corpus Cancer, +1 more
- Locations
-
- Gynecologic Oncology Group Philadelphia, Pennsylvania, United States
Related conditions
- Stage III Uterine Corpus Cancer (10)
- Stage I Uterine Corpus Cancer (6)
- Stage II Uterine Corpus Cancer (6)
- Recurrent Uterine Corpus Carcinoma (5)
- Endometrial Adenocarcinoma (3)
- Endometrial Serous Adenocarcinoma (3)
- Female Urogenital Diseases (3)
- Female Urogenital Diseases and Pregnancy Complications (3)